• Immunogenicity Assessment

    • Therapeutic In Silico Services
      • ISPRIâ„¢ Website
      • ISPRI Downselectâ„¢
      • ISPRI Quantifyâ„¢
      • ISPRI Analyzeâ„¢
      • ISPRI Evaluateâ„¢
      • ISPRI-HCPâ„¢
      • ISPRI Designâ„¢
      • PANDA® Screening
    • Vaccine In Silico Services
      • iVAXâ„¢
      • EpiCCâ„¢
      • Ancer®
      • PreVAXâ„¢
    • Lab Services
      • HLA Binding Assay
      • Naive CD4+ T Cell Assay
      • Innate Assay
    • Consulting Services
  • About Us
    • Leadership
    • Careers
  • Partner
  • Press
    • News
    • Events
    • Publications
    • Blog
  • Contact Us
Better Epitope Discovery, Precision Immune Engineering, and Accelerated Vaccine Design Using Immunoinformatics Tools

Better Epitope Discovery, Precision Immune Engineering, and Accelerated Vaccine Design Using Immunoinformatics Tools

by Annie De Groot | Apr 13, 2020

Better Epitope Discovery, De Groot et.al. 2020
Better Epitope Discovery, Precision Immune Engineering, and Accelerated Vaccine Design Using Immunoinformatics Tools

T cell epitope content comparison (EpiCC) analysis demonstrates a bivalent PCV2 vaccine has greater T cell epitope overlap with field strains than monovalent PCV2 vaccines

by Annie De Groot | Apr 9, 2020

2020 Bandrick et al. EpiCC
In silico identification and modification of T cell epitopes in pertussis antigens associated with tolerance

In silico identification and modification of T cell epitopes in pertussis antigens associated with tolerance

by Annie De Groot | Jan 22, 2020

Kruiswijk et al 2020 – In silico identification and modification of T cell epitopes in pertussis antigens associated with tolerance
Vaccine Optimization by Identification, Characterization, and Downselection of Human T Cell Epitopes from Plasmodium falciparum Circumsporozoite Protein.

Vaccine Optimization by Identification, Characterization, and Downselection of Human T Cell Epitopes from Plasmodium falciparum Circumsporozoite Protein.

by Annie De Groot | Nov 23, 2019

Vaccine Optimization by Identification, Characterization, and Downselection of Human T Cell Epitopes from Plasmodium falciparum Circumsporozoite Protein.
Modulation of B. pseudomallei Immune Responses by Human-like T Cell Epitopes

Modulation of B. pseudomallei Immune Responses by Human-like T Cell Epitopes

by Annie De Groot | Nov 20, 2019

Modulation of B. pseudomallei Immune Responses by Human-like T Cell Epitopes
« Older Entries
Next Entries »

Recent Posts

  • The Platinum Vaccine & Change is Good!
  • EpiVax Appoints Dr. Vibha Jawa to Lead Scientific Strategy as CSO
  • Smarter Tools, Safer Therapies: Supporting the FDA’s Roadmap with in silico Immunogenicity Assessment
  • The Amsterdam Immunogenicity & Tolerance Seminar: 2025
  • The Westin Immunogenicity Seminar

Recent Comments

No comments to show.

Join our newsletter

Stay up to date with EpiVax and greater industry news, events, and technological advancements with this monthly update written by EpiVax co-founder and CMO, Dr. Annie De Groot.

Explore

Therapeutic In Silico Services

Vaccine In Silico Services

Lab Services

Consulting

LinkedIn

About Us

Careers

Partner

News

Events

Publications

Contact Us

We use cookies to ensure that we give you the best experience on our website. By clicking 'accept', you consent to our use of cookies.